Can excess monoclonal proteins cause neurologic symptoms by increasing serum viscosity?

Excess monoclonal proteins can produce clinically important hyperviscosity, particularly in IgM-associated disorders such as Waldenström macroglobulinemia, and can compromise cerebral microvascular perfusion. This mechanism is directly relevant when new neurologic, visual, or bleeding symptoms accompany paraproteinemia.

Clinical and mechanistic evidence

• Large or polymerized plasma proteins directly raise serum/plasma viscosity. Pentameric IgM (approximately 925–970 kDa) is especially potent; viscosity may increase sharply above roughly 3 g/dL. Polymerized IgG3 and IgA can also have disproportionate effects compared with monomeric immunoglobulins.
• Increased plasma and whole-blood viscosity limits flow in small vessels, causing microvascular stasis and hypoperfusion. Cerebral blood flow correlates more closely with whole-blood viscosity than hematocrit, supporting viscosity—not reduced oxygen-carrying capacity—as the principal perfusion mechanism.
• Neurologic consequences range from headache, dizziness, vertigo, and confusion to focal deficits, seizures, stroke, coma, and death. Vascular complications involving retinal, peripheral, and central nervous system circulations occurred in >80% of patients with viscosity >60 cP versus <23% below 40 cP.

Additional vascular manifestations

• Paraproteins can promote low-shear erythrocyte aggregation, adding to impaired microvascular perfusion.
• Retinal venous congestion, hemorrhages, edema, delayed arteriovenous transit, and occasional retinal vein occlusion provide visible evidence of this microcirculatory disturbance.

Practical implications

• Normal serum viscosity is about 1.4–1.8 cP. Symptoms are uncommon below ~4 cP and more frequent above 4–5 cP, but individual thresholds vary with protein properties and patient susceptibility.
• Direct viscometry, rather than immunoglobulin concentration alone, confirms hyperviscosity. Acute neurologic, visual, or mucosal-bleeding symptoms in this setting warrant urgent management; plasma exchange can rapidly lower viscosity while treatment of the underlying clone limits recurrent protein production.

Bottom line

• The claim is strongly supported: excess monoclonal or other large plasma proteins can increase viscosity, reduce microcirculatory—especially cerebral—flow, and cause neurologic manifestations.